Therapeutic potential of inhibitory VEGF splice variants

By Bates David O   Harper Steven J  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 467-473

Future Medicine

Access to resources Recommend Favorite

Alpha-v Integrins as Therapeutic Targets in Oncology

By Nemeth Jeffrey   Nakada Marian   Trikha M.   Lang Zhihui   Gordon Michael   Jayson Gordon   Corringham Robert   Prabhakar Uma   Davis Hugh   Beckman Robert  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 632-646

Informa Healthcare

Access to resources Recommend Favorite

Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma

By Lee Y.H.   Tokunaga T.   Oshika Y.   Suto R.   Yanagisawa K.   Tomisawa M.   Fukuda H.   Nakano H.   Abe S.   Tateishi A.   Kijima H.   Yamazaki H.   Tamaoki N.   Ueyama Y.   Nakamura M.  

European Journal of Cancer, Vol. 35, Iss. 7, 1999-07 ,pp. : 1089-1093

Elsevier

Access to resources Recommend Favorite

The pivotal role of VEGF in tumor angiogenesis: Molecular facts and therapeutic opportunities

By Siemeister G.   Martiny-Baron G.   Marmé D.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 241-248

Springer Publishing Company

Access to resources Recommend Favorite

Cancer genome sequencing and potential application in oncology

By Katsios Christos   Zoras Odysseas   Roukos Dimitrios H  

Future Oncology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1527-1531

Future Medicine

Access to resources Recommend Favorite